Objective Polyunsaturated fatty acids (PUFAs) are associated with heart failure (HF) as well as coronary artery disease. However, little is known about the relationships between PUFAs and the exercise responses of patients with HF. We evaluated the relationships between PUFAs and the parameters of cardiopulmonary exercise tests (CPETs) in patients with non-ischemic HF. Methods Fifty patients with stable non-ischemic HF underwent CPETs at our hospital. Data were analyzed to evaluate the relationships between PUFAs and echocardiographic findings as well as CPET and other test parameters. Results Correlations were significant and negative between dihomo-γ-linolenic acid (DGLA) + arachidonic acid (AA) and minute ventilation versus carbon dioxid...
The clinical significance of polyunsaturated fatty acids (PUFAs) in acute decompensated heart failur...
The n-3 polyunsaturated fatty acids (PUFA) have been proposed as potential treatments for human hear...
Background: Intake of long-chain n-3 polyunsaturated fatty acids (n-3 PUFA), including docosahexaeno...
Objective Polyunsaturated fatty acids (PUFAs) are associated with heart failure (HF) as well as coro...
Objective: Polyunsaturated fatty acids (PUFAs) are associated with heart failure (HF) as well as cor...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Many new clinical trials about the effect of omega-3 polyunsaturated fatty acids (PUFAs) in heart fa...
BACKGROUND Circulating long-chain (LCSFAs) and very long-chain saturated fatty acids (VLSFAs) hav...
OBJECTIVES The intention of this study was to test the hypothesis that, in heart failure patients, d...
AIMS: In the last few years, n-3 polyunsaturated acids (PUFAs) have been extensively studied for the...
AbstractBackgroundIntake of n-3 polyunsaturated fatty acids (n-3 PUFAs) lowers the risk of atheroscl...
Background: Although 1 in 5 adults will develop heart failure (HF) in their lifetime, currently data...
Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty acids (PUFA)...
Background Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcome...
The clinical significance of polyunsaturated fatty acids (PUFAs) in acute decompensated heart failur...
The n-3 polyunsaturated fatty acids (PUFA) have been proposed as potential treatments for human hear...
Background: Intake of long-chain n-3 polyunsaturated fatty acids (n-3 PUFA), including docosahexaeno...
Objective Polyunsaturated fatty acids (PUFAs) are associated with heart failure (HF) as well as coro...
Objective: Polyunsaturated fatty acids (PUFAs) are associated with heart failure (HF) as well as cor...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Many new clinical trials about the effect of omega-3 polyunsaturated fatty acids (PUFAs) in heart fa...
BACKGROUND Circulating long-chain (LCSFAs) and very long-chain saturated fatty acids (VLSFAs) hav...
OBJECTIVES The intention of this study was to test the hypothesis that, in heart failure patients, d...
AIMS: In the last few years, n-3 polyunsaturated acids (PUFAs) have been extensively studied for the...
AbstractBackgroundIntake of n-3 polyunsaturated fatty acids (n-3 PUFAs) lowers the risk of atheroscl...
Background: Although 1 in 5 adults will develop heart failure (HF) in their lifetime, currently data...
Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty acids (PUFA)...
Background Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcome...
The clinical significance of polyunsaturated fatty acids (PUFAs) in acute decompensated heart failur...
The n-3 polyunsaturated fatty acids (PUFA) have been proposed as potential treatments for human hear...
Background: Intake of long-chain n-3 polyunsaturated fatty acids (n-3 PUFA), including docosahexaeno...